ProQR Therapeutics NV (NASDAQ:PRQR)

7.25
Delayed Data
As of Nov 26
 -0.17 / -2.31%
Today’s Change
3.40
Today|||52-Week Range
9.46
+72.62%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 21.44, with a high estimate of 36.90 and a low estimate of 17.00. The median estimate represents a +195.78% increase from the last price of 7.25.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in ProQR Therapeutics NV. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$853.1K
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.10%
 
 
 
 
 
 
Growthannually 2.24%
 
 
 
 
 
 

Sales

Growthquarterly -2.16%
 
 
 
 
 
 
Growthannually -71.77%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.